Nationwide Recall Issued for Lot of Hospira Hydromorphone Injection

Hospira has issued a voluntary nationwide recall of one lot of Hydromorphone Injection, according to the American Society of Anesthesiologists.

A single complaint reported that one Carpuject contained more than the 1mL labeled volume. If opioid pain medications, such as Hydromorphone, are overdosed, consequences could be life-threatening respiratory depression, low blood pressure and reduced heart rate.

The affected lot number is 12720LL, and its expiration date is Dec. 1, 2013.

More Articles on Product Recalls:
Recall Issued for Hospira Injectable Anesthesia Product
FDA Warns of Risk of Death From Codeine in Children Following Surgery
Covidien Initiates Voluntary Recall of Tracheostomy Tubes


Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast